ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
COMPASS Pathways PLC

COMPASS Pathways PLC (CMPS)

8.18
0.24
( 3.02% )
Updated: 12:30:08

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
8.18
Bid
8.17
Ask
8.19
Volume
110,875
7.8581 Day's Range 8.19
0.00 52 Week Range 0.00
Market Cap
Previous Close
7.94
Open
7.94
Last Trade
1
@
8.19
Last Trade Time
12:33:09
Financial Volume
$ 886,598
VWAP
7.9964
Average Volume (3m)
-
Shares Outstanding
-
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About COMPASS Pathways PLC

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing ther... Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360. Show more

Sector
Offices-holdng Companies,nec
Industry
Offices-holdng Companies,nec
Headquarters
Cheshire, Gbr
Founded
1970
COMPASS Pathways PLC is listed in the Offices-holdng Companies sector of the NASDAQ with ticker CMPS. The last closing price for COMPASS Pathways was $7.94. Over the last year, COMPASS Pathways shares have traded in a share price range of $ 0.00 to $ 0.00.

COMPASS Pathways currently has 0 shares outstanding.

CMPS Latest News

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

LONDON, April 29, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in...

Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors

LONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in...

Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights 

LONDON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Highlights: COMP360 phase 3 pivotal program ongoing; COMP005 trial top-line data now expected in fourth quarter 2024, COMP006 remains on track for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CAUDCollective Audience Inc
$ 0.7348
(88.41%)
135.23M
DCPHDeciphera Pharmaceuticals Inc
$ 25.21
(72.08%)
39.05M
HWHHWH International Inc
$ 2.5401
(39.57%)
22.17M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.675
(35.31%)
59.39M
TSLTT Rex 2X Long Tesla Daily Target ETF
$ 13.23
(35.28%)
10.16M
CLVRClever Leaves Holdings Inc
$ 1.5702
(-61.80%)
604.91k
ADXNAddex Therapeutics Ltd
$ 8.35
(-48.14%)
116.17k
TSDDGraniteShares ETF Trust GraniteShares
$ 16.14
(-35.18%)
1.08M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 25.51
(-35.04%)
5.29M
MFImF International Ltd
$ 1.542
(-33.82%)
2.36M
TSLATesla Inc
$ 197.866
(17.57%)
150.91M
CAUDCollective Audience Inc
$ 0.7348
(88.41%)
135.23M
SINTSiNtx Technologies Inc
$ 0.0527
(30.45%)
133.86M
SOFISoFi Technologies Inc
$ 7.085
(-9.97%)
109.83M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.675
(35.31%)
59.39M

CMPS Discussion

View Posts
Monksdream Monksdream 2 months ago
CMPS new 52 week high
👍️0
Monksdream Monksdream 3 months ago
CMPS new 52=week high
👍️0
Copilotdog Copilotdog 5 months ago
There will be no mushroom boom. The Fed’s will crush it. Shorting this to $3
👍️0
Monksdream Monksdream 5 months ago
This podcast is an absolute screaming hilarious analysis of psycho stocks
👍️0
Monksdream Monksdream 6 months ago
Uh, you know, we live now in technology driven world
In times past ever since the Industrial Revolution wealth was created primarily from natural resources
But that isn’t exactly the etched in stone fact
Prior to the mid-1850s there was the Scientific Revolution that began in the 1400s
The academic discipline of chemistry in some unforeseen way led to the accidental discovery by a Swiss chemist who walked to his lab well into his 80s
That said, as far as US stock market sectors are concerned, the medical sector is by far the largest in terms of the number of companies in which a retail or professional asset manager deploying other people’s money can invest
Close to 1 000 public traded companies
It is in my view pretty much a crap shoot when it comes finding one that is equivalent to Microsoft
With that said one should, in the long run, expect disappointment to be the norm rather than the exception
👍️0
LORTAP KCOTS LORTAP KCOTS 6 months ago
Last time I owned this, was when I sold it over $70, really dodged a bullet on this one.. unfortunately I own MNMD.. and it’s just as bad of a fall down shit show
👍️0
Monksdream Monksdream 6 months ago
CMPS new 52 week low
👍️0
Monksdream Monksdream 10 months ago
CMPS over $10

https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 10 months ago
CMPS nearing resistance break it and it goes higher
👍️0
Denisnj Denisnj 12 months ago
Definitely overpriced. Government needs slaves. No way they'll let humanity awaken
👍️0
starman2 starman2 2 years ago
https://investorplace.com/2022/07/dear-psychedelic-stocks-fans-watch-this-key-catalyst/
👍️0
starman2 starman2 2 years ago
https://www.benzinga.com/analyst-ratings/analyst-color/22/08/28522479/these-depression-players-are-hc-wainwrights-top-picks-for-400b-mental-healthcare-ma

(shared via bit.ly/mystocksapp)
👍️0
starman2 starman2 2 years ago
On fire.. So glad i jumped in.
👍️0
ListenToMe ListenToMe 2 years ago
Are you peeps watching PSYCF? I definitely think it's going to become the LEADER and Catalyst for the Mushroom sector!
👍️0
ListenToMe ListenToMe 2 years ago
Best mushroom play is PSYCF!!! Pay Attn.


.PSYCF





.
👍️0
ListenToMe ListenToMe 2 years ago
Awesome mushroom video & sound With its iconic red cap & white spots, our mushroom is the most recognizable mushroom in pop culture. It's often pictured in children's books, creating an association with magic and fairies, and tales told about the mushroom evoke an inner journey to the psyche.$PSYC $PSYC.C pic.twitter.com/XPTZXGY09C— Psyched Wellness (@PsychedWellness) January 5, 2022
👍️0
BesaoT35 BesaoT35 2 years ago
Psychedelics are very safe drugs. A long term remission in treatment resistant major depression is a highly valuable and rare benefit to achieve for these patients.

On occasion there are reported cases of a psychosis induced, usually when that happens it is on very large doses of psychedelics perhaps combined with a non supportive environment.

Psilocybin causes fewer of these outcomes I have heard and is perhaps a less intense experience. Psilocybin is known to be a shorter acting psychedelic than LSD is.

Sedatives such as Valium or Xanax should be available if needed or desired at the end of the session in my opinion. Otherwise the process of coming down from the peak experience can be a drawn out and somewhat unpleasant process.
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
I love this stock!! Just flipped this for a $1500 profit in 24 hrs..
👍️0
BesaoT35 BesaoT35 2 years ago
The clinical study for Treatment Resistant Major Depression looked very successful. Can a psychiatrist prescribe this patented psilocybin similar to how cannabis is illegal but medical doctors recommend it’s use legally for medical dispensaries?

How are they able to patent a known plant chemical? They claim to have a patented form of psilocybin.
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Thank god I sold this.
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
This stock has really come back nicely!!
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Awesome, just made $7700 on this trade!!!
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Crushing upward today!!
👍️0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Nice volume and nice price movement
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
This thing is moving up!!!
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Big news today!!!
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Steady increases, looks like we can get past $40 and then maybe $50?
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
WTF???
👍️0
Glider549 Glider549 3 years ago
Sure was.
Schroom pharma is really advancing.
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Nice movement today
👍️0
Tower of Hanoi Tower of Hanoi 3 years ago
Nice interview. Now that ketamine therapy is in use, I really don't see any significant roadblocks to further expansion into other drugs.

Execution will be critical, plus how many competitors end up in the space.
👍️0
Investopotia Investopotia 3 years ago
New CEO Interview
👍️0
Tower of Hanoi Tower of Hanoi 3 years ago
I can't think of a better speculative space right now!

GLTA!
👍️0
Tower of Hanoi Tower of Hanoi 3 years ago
Tiny, tiny position today:

10 shares @35.

Nice spec.


MY OPINION ONLY.
👍️0
0001-stocks 0001-stocks 3 years ago
NEW BOARD!!! Psychedelic Stocks (link here)

https://investorshub.advfn.com/Psychedelic-Stocks-39490/
👍️0
ReviveThomas ReviveThomas 3 years ago
I've eyeballed CMPS but not new to shroom stocks. What's the deal with this. Clinicaltrials.gov trial for treatment resistant depression in may ? Is that right?
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 years ago
Up 4.05
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 years ago
Going up
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 years ago
Could this we thousands dollar stock lollllll
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 years ago
Wowwwwwww
👍️0
WebSlinger WebSlinger 3 years ago
***PR OUT***

COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences

London, UK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of its management team will participate in two investor conferences during the week of 11 January 2021.

George Goldsmith, Chairman, CEO and Co-founder, and Lars Wilde, President, Chief Business Officer, and Co-founder, will be participating in a fireside chat available on demand from 11 to 14 January in conjunction with the HC Wainwright BioConnect 2021 Conference.

George Goldsmith and Lars Wilde will also present a business update and hold a fireside chat at 12:15 pm ET on 14 January at the Westwicke Healthcare Day at the ICR Conference 2021.

Audio webcasts of the fireside chats will be available on the "Events" page of the Investors section of the COMPASS website at https://ir.compasspathways.com/news-events/events. A replay of events will be available for 30 days following the event.

https://www.globenewswire.com/news-release/2021/01/06/2154099/0/en/COMPASS-Pathways-plc-to-participate-in-HC-Wainwright-and-ICR-investor-conferences.html
👍️0
excboe excboe 3 years ago
CMPS ARTICLE. Sketchy https://www.google.com/amp/s/qz.com/1454785/a-millionaire-couple-is-threatening-to-create-a-magic-mushroom-monopoly/amp/
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 3 years ago
Wowwwwww so much cash
👍️0
WebSlinger WebSlinger 3 years ago
CMPS has $196.5 MILLION in cash (as of 30 Sep 2020)

That should hold them for about 4 years at the current burn rate of about $50 million per year.

https://sec.report/Document/0001628280-20-016249/
👍️0
Fress Fress 3 years ago
Anxiety depression drug companies.
1.VTGN market cap $150 million 115 million in cash has Phase 3 & Phase 2's (Pandemic through U.S. FDA's Coronavirus Treatment Acceleration Program (CTAP)
2 $CMPS2.0 BILLIION early trials 180 million cash
3 $MMED 1.1 BILLION phase 2 raised 40 million in cash
4 $SAGE 3 Billion market cap bought out a few weeks ago for deperession anxiety pipeline


$CMPS
👍️0
weedtrader420 weedtrader420 3 years ago
CMPS $70 Target price this week
👍️0
weedtrader420 weedtrader420 3 years ago
CMPS on the road to $100 woohooooooooo
👍️0
MomsSpaghetti MomsSpaghetti 3 years ago
I am in this and MMEDF. Both of these are the horses.
👍️0
CHARLIE125 CHARLIE125 3 years ago
CMPS
OREGON legal.PSILOCIBIN WILL BE LEGAL THIS YEAR.
RUMOR IS OUT
PAYPAL ceo is buying more here
👍️0
AlphaStockNews AlphaStockNews 3 years ago
If you're watching $CMPS, you've gotta take a look at $SILO https://alphastocknews.com/silo-pharma-silo-stock-to-climb-on-planned-clinical-trial/4880/
👍️0

Your Recent History

Delayed Upgrade Clock